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Abstract
Background: Overproduction of free radical species has been shown to occur in brain tissues
after ischemia-reperfusion injury. However, most of free radical scavengers known to antagonize
oxidative damage (e.g. superoxide dismutase, catalase), are unable to protect against ischemia-
reperfusion brain injury when given in vivo, an effect mainly due to their difficulty to gain access to
brain tissues. Here we studied the effect of a low molecular weight superoxide dismutase mimetic
(M40401) in brain damage subsequent to ischemia-reperfusion injury in Mongolian gerbils.
Results: In animals undergoing ischemia-reperfusion injury, neuropathological and ultrastructural
changes were monitored for 1–7 days either in the presence or in the absence of M40401 after
bilateral common carotid artery occlusion (BCCO). Administration of M40401 (1–40 mg/kg, given
i.p. 1 h after BCCO) protected against post-ischemic, ultrastructural and neuropathological changes
occurring within the hippocampal CA1 area. The protective effect of M40401 was associated with
a significant reduction of the levels of malondialdehyde (MDA; a marker of lipid peroxidation) in
ischemic brain tissues after ischemia-reperfusion.
Conclusion: Taken together, these results demonstrate that M40401 provides protective effects
when given early after the induction of ischemia-reperfusion of brain tissues and suggest the
possible use of such compounds in the treatment of neurological dysfunction subsequent to
cerebral flow disturbances.
Background
Transient or permanent restriction of cerebral blood flow
results in ischemic stroke, the third leading cause of death
in industrialized countries. Many pathophysiological
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mechanisms involved in post-ischemic damage of nerv-
ous tissues have been widely explored over the last few
years in order to develop selective and more suitable strat-
egies for the treatment of ischemia/reperfusion-related
neurological disorders [1–6]. In particular, mounting evi-
dence suggests that a crucial role in triggering and main-
taining the post-ischemic insult to brain tissues is
represented by the oxidative stress which follows the
reperfusion phase of stroke. Reperfusion of the ischemic
brain, excessive release of excitatory amino acids, such as
glutamate, and infiltration by neutrophils are major
sources of reactive oxygen species (ROS) generation.
These, in turn, amplify the profound imbalance found in
the neurons and astroglial cells of the ischemic core and
penumbra [7]. In particular, the reaction of superoxide
anions with nitric oxide (NO), leads to the formation of
peroxynitrite (ONOO-) [8], a powerful damaging oxidant
and nitrating agent, which may induce many of the per-
manent ultra structural changes of ischemic brain tissue
[9,10].
Despite the large amount of evidence showing the clear
relationship between oxidative stress and post-ischemic
brain damage, neuroprotection by free radical-scavenging
molecules in vivo is not as straightforward as that observed
when using in vitro models. In particular, superoxide dis-
mutase (SOD) as well catalase, the catalytic scavengers for
superoxide anions or hydrogen peroxide respectively,
while producing a significant neuroprotective effect in
vitro, were found unsatisfactory when used in experimen-
tal stroke models in vivo [11–14]. The reasons for such
failures are not clear, but could be related to various fac-
tors including rapid clearance, lack of cellular penetration,
short half-life and lack of blood brain barrier penetration
[15–17]. On the other hand, these enzymes show modest
protective effects when treatment is administered before
ischemia, but little to no protection in a delayed-treat-
ment protocol [14].
To overcome some of the limitations associated with the
native SOD enzymes, low molecular weight synthetic
enzymes possessing improved cellular and tissue penetra-
tion, with wide organ bio-distribution have been identi-
fied. One of these, EUK 134, a low molecular weight salen
manganese complex was found to be protective when
given in a rat model of focal cerebral ischemic without
reperfusion [18]. Since EUK 134 possesses both SOD and
catalase activity, these results suggest a role for both super-
oxide and hydrogen peroxide in brain damage evoked by
ischemia without reperfusion.
Recently, a class of non peptidic low-molecular weight
compounds proven to possess comparable catalytic activ-
ity to that of the native superoxide dismutase (SOD)
enzymes has been reported, and the use of these com-
pounds has been suggested for assessing an improved
therapeutic approach in diseases mediated by superoxide
overproduction [19,20]. In particular, evidence exists sug-
gesting that M40401 [21], an SOD mimetic compound
able to gain access to brain tissues, produces protective
effect against oxidative damage generated in the brain of
paraquat-treated rats, when given peripherally [22]. These
new SOD mimetics represent a breakthrough in chemical
design in that they are stable in vivo, possess high activity,
and are selective for superoxide with no activity toward
H2O2, peroxynitrite, nitric oxide, or hypochlorite [23–25].
The present experiments have been carried out in order to
study 1) the possible role of superoxide in electrocortical
and ultra structural changes subsequent to brain damage
associated with ischemia and reperfusion induced by uni-
lateral occlusion of carotid artery (BCCO) in Mongolian
gerbils, and 2) the protective effect of a SOD mimetic
(M40401) which lacks catalase activity against ischemia-
reperfusion brain damage.
Results
Effects of ischemia-reperfusion in the hippocampus of 
Mongolian gerbils
Induction of BCCO in Mongolian gerbils produced signif-
icant early neuropathological and ultrastructural changes,
which were followed by significant neuronal loss within
the CA1 area of gerbil's hippocampus. In particular, histo-
logical and ultrastructural evaluation carried out at day 1
after induction of brain ischemia showed significant inci-
dence, compared to sham operated animals (n = 10; Fig-
ure 1A), of eccentric pycnotic nuclei, intracellular oedema
and vacuolar degeneration (n = 10; Figure 1B) found in
CA1 and partially in CA2 areas of gerbil's hippocampus.
CA3, CA4 and Dentate gyrus (DG) showed a normal
cytoarchitecture (n = 10; not shown). Furthermore, the
examination of brain tissues by electron microscopy car-
ried out 1 day after the ischemic insult showed, within
CA1 area of the hippocampus of gerbils, the presence of
vacuolated neurons with irregular shaped nuclei com-
posed of euchromatin with margination of heterochro-
matin; in a few cells, large electron-light vacuoles
occupied the entire cytoplasm and the cell shape was not
maintained. Moreover, the mitochondria were dense and
disorganized. In the same area, a few glial cells showed a
suffering phenotype characterized by dispersion of the
chromatin into the cytoplasm due to the absence of the
nuclear membrane, nucleoli still prominent, dense cyto-
plasm with small vacuolization and endoplasmic reticu-
lum preserved; the plasma membrane was not always
visible and often interrupted and in the extracellular space
myelinic fibers with alteration of the myelinic structure
are visible (n = 10; Figure 2A,2B,2C). These features were
not visible in sham animals where neurons and glial cells
showed a normal cytoarchitecture.BMC Pharmacology 2003, 3 http://www.biomedcentral.com/1471-2210/3/8
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Figure 1
Temporary (5 min) BCCO in Mongolian gerbils leads to damage in the hippocampal CA1 area, compared to sham-operated 
animals (A), characterized by neurons showing eccentric pycnotic nuclei, intracellular edema and vacuolar degeneration (B). 
M40401 (40 mg/Kg) given i.p. 1 h after BCCO protected against ischemia-reperfusion hippocampal early lesion (C)
A
B
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Figure 2
(A-C): ischemia + 1 day recovery: prominent ultrastructural damages of CA1 area of the hippocampus in the site of carotid 
artery occlusion. In particular, are displayed vacuolated neurons with irregular nuclei and margination of the heterochromatin 
(pre-apoptotic neurons). Large electron light vacuoles occupy the cytoplasm and the mitochondria are dense and disorganized. 
In many cells, vacuoles occupy the entire cytoplasm, cell shape is not maintained and the chromatin is dispersed into the cyto-
plasm (see A). (magnification × 3800). (D) M40401 (40 mg/kg) protected against damage. Indeed, the micrographs show the 
presence, in the hypothalamic CA1 area of normal neurons with large nuclei with euchromatin and prominent nucleoli. In addi-
tion, developed mitochondria, rough endoplasmic reticulum and normal cytoskeleton components are distinguished. In the 
extracellular space are found preserved myelinic fibers and blood vessels. (magnification × 3800)BMC Pharmacology 2003, 3 http://www.biomedcentral.com/1471-2210/3/8
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The early post-ischemic lesion seen 1 day after BCCO was
accompanied by loss of neurons within CA1 area when
evaluated 7 days after induction of global ischemia.
Indeed, in a group of 10 animals undergoing BCCO,
histological examination of brain slices carried out at the
day 7 after brain ischemia showed significant reduction in
the number of neurons detected within CA1 area of ger-
bil's hippocampus compared to sham operated animals
(n = 10; Figure 3A and 3B).
Effects of M40401
Administration of M40401 (1–40 mg/Kg i.p. 1 h after
BCCO; n = 10 for each dose), produced a significant and
dose-dependent reduction of neuropathological and
ultrastructural early changes within the hippocampus of
gerbils undergoing ischemia-reperfusion (Figure 3B and
4D). Thus, the administration of M40401 (1–40 mg/Kg
given i.p, after BCCO, n = 10 for each dose) in Mongolian
gerbils reduced by 18 ± 4, 36 ± 2, 72 ± 4 and 100%, respec-
tively, the number of cells showing ultrastructural changes
in the hippocampus found 1 days after induction of
BCCO. Sham operated Mongolian gerbils treated with 1–
40 mg/kg i.p. of M40401 (n = 10 for each dose) did not
show any significant histopathological and ultrastructural
modification when compared to sham non-treated Mon-
golian gerbils (data not shown). Results showing lack of
BCCO-related early damage in the hippocampal area after
the highest dose of M40401 (40 mg/kg, i.p, n = 10) are
shown in Figure 1C and 2D. In addition, M40401 (40 mg/
Kg given i.p. 1 h after BCCO; n = 10), lead to protective
effect against neuronal loss seen 7 days after BCCO within
the CA1 area of the gerbil's hippocampus (Figure 3A and
3B).
Effect of M40401 in the post-ischemic elevation of MDA in 
brain tissues
Ischemia-reperfusion was followed by significant eleva-
tion of the concentration of MDA in ischemic brain,
mainly within the hippocampus. This effect was observed
Figure 3
Panel A. Representative histological examination of brain hip-
pocampus of Mongolian gerbil's showing significant neuronal 
loss within CA1 area, compared to sham operated animals, 
when evaluated 7 days after induction of BCCO. Panel B 
shows quantitative analysis for CA1 hippocampal neurons 
detected in sham-operated and BCCO-operated animals 
either untreated or treated with M40401. In particular, 
M40401 (40 mg/Kg given i.p. 1 h after BCCO; n = 10) 
showed protective effect against ischemia-reperfusion-
induced reduction of neuronal cell number detected within 
CA1 hippocampal area.
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Figure 4
Time-dependent elevation of malondialdehyde levels (MDA, 
nmol/g tissue) within the hippocampus of Mongolian gerbils 
(A). The increase of MDA found 1 day after BCCO was 
attenuated dose-dependentently by M40401 (1–40 mg/kg; n 
= 10 for each dose; B). * P < 0.05 ischemic vs M40401-
treated gerbils.
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3–6 h after brain ischemia, peaked 1–3 days after occlu-
sion then decreased toward the baseline value (Figure 4A).
M40401 (1–40 mg/kg; Figure 4; n = 10 for each dose),
dose-dependently attenuated the increase of MDA levels
detected in the hippocampus 1 day after BCCO suggesting
that, in this model, the SOD mimetic was able to reduce
lipid peroxidation in injured brain (Figure 4B).
Discussion
It is known that ischemia-reperfusion of brain tissue is fol-
lowed by an increased production of reactive oxygen spe-
cies (ROS) (mainly superoxide anion, hydroxyl radical
and hydrogen peroxide) which, in turn, participate in the
mechanisms leading to post-ischemic neuronal cell death
and apoptosis of neuronal and non neuronal cells
[26,27]. Importantly, accumulation of free fatty acids and
adenine nucleotides has been described over the ischemic
period after both global and focal ischemia in the brain.
Thus, during reperfusion, metabolism of free fatty acids
(via cycloxygenase and lipoxygenase activation) and of
adenine nucleotides (via xanthine oxidase activity) leads
to ROS overproduction [8,10,28–31]. This is further
accompanied by leukocyte infiltration, which generates
both ROS and nitric oxide which, in turn, contribute to
the generation of highly reactive and neurotoxic nitrogen
free radical species, such as peroxynitrite [8,10].
The antioxidant status of the tissue affected by ischemia-
reperfusion is of great importance for the primary endog-
enous defense against the free radical-induced injury. In
particular, evidence exists that the SOD activity in serum
is reduced in stroke patients, and replacement of antioxi-
dant activity could be beneficial in the acute treatment of
cerebral ischemia [32]. In addition, it has been suggested
that O2 
- overproduced in a mitochondrial compartment,
when uncoupled from antioxidant defenses, induces
impairment of mitochondrial function and causes exacer-
bation of cerebral infarction after ischemia [33]. Moreo-
ver, it has also been shown that the endogenous
antioxidant activity is differentially affected by the inten-
sity of ischemic challenge and this suggests that the
regional effects of ROS vary substantially following
ischemia-reperfusion [34]. Thus, changes in the antioxi-
dant status of brain tissues before, during and after
ischemia-reperfusion greatly affects post-ischemic brain
damage and has been widely studied in the last few years.
In fact evidence has been acquired showing that extracel-
lular superoxide dismutase deficiency worsens outcomes
from focal cerebral ischemia in the mouse [35]. In partic-
ular, it has been shown that delayed cell injury after tran-
sient global ischemia is exacerbated in mutant mice
deficient in Cu/Zn SOD [36]. Also, evidence exists show-
ing that reduction of Cu/Zn-superoxide dismutase activity
exacerbates neuronal cell injury, apoptotic cell death and
edema formation after transient focal cerebral ischemia
[37]. An enhanced expression of endogenous antioxidants
significantly attenuates ischemia-reperfusion injury of
brain tissues, however, the use of SOD enzyme is limited
by its pharmacological profile [33,38–43].
On the basis of this evidence, it is likely that an additional
supply of antioxidant moieties over and above the natural
SOD enzyme levels is crucial for a selective protection of
brain tissue against ischemic injury [43,44]. In particular,
the discovery that metalloporphyrin complexes of Mn and
Fe that possess the capacity to destroy superoxide, perox-
ynitrite, and hydrogen peroxide show efficacy in models
of disease states involving free radical overproduction has
heightened interest in the development of novel antioxi-
dants which have been found to possess selective catalytic
superoxide dismutase mimetic activity [19,20,22,23,45].
In the present experiments we demonstrate that M40401,
one of the most active non-peptidic SOD mimetic
reported, produces a relevant and significant protective
effect against neuropathological and ultrastructural
changes elicited by temporary BCCO in Mongolian ger-
bils. This confirms the involvement of superoxide-over-
production in ischemia-reperfusion injury and suggests a
potential therapeutic role of such free radical scavengers
in early stages of the retrograde and anterograde spread of
neurotoxicity. The evidence that M40401 produces a sig-
nificant protection of brain tissues against post-ischemic
brain injury is relevant since this indicates that this com-
pound reaches concentrations in the brain able to develop
pharmacological SOD mimetic activity when given
peripherally. Antioxidant effect at the level of the brain
was in fact confirmed by the reduction of lipid peroxida-
tion as shown by the reduction of MDA formation in
brain tissues of ischemic Mongolian gerbils treated with
M40401.
In conclusion, our results indicate that low molecular
weight synthetic SOD mimetic which lack catalase activity
may represent a novel and potentially useful approach in
the treatment of many neurodegenerative disorders, such
as ischemia/reperfusion brain injury, in which an abnor-
mal release of free radicals has been shown to occur.
Methods
Bilateral Common Carotid Artery Occlusion and electro-
cortical recordings
Adult male Mongolian gerbils (Meriones unguiculatus, 50–
70 g; Charles River, Milan, Italy), housed in a temperature
(20°C) and humidity (60%) – controlled colony room,
were used for this study. The colony was maintained in a
12 h light/dark cycle with light on at 7:00 a.m. and both
laboratory food and tap water were available ad libitum.
Under chloral hydrate (400 mg/Kg i.p.) anesthesia, 4
stainless steel wire electrodes were chronically implanted
onto each fronto-parietal cortex under stereotaxicBMC Pharmacology 2003, 3 http://www.biomedcentral.com/1471-2210/3/8
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guidance; the ground electrode was anchored to the nasal
bone. Animals were allowed one week recovery before
testing. Before experiments, the animals were placed indi-
vidually in a perspex cage and allowed 30 min
acclimatization to the new environment. Electrocortical
(ECoG) recordings were made via an EEG machine (Mod.
ERA-9; OTE Biomedica, Florence, Italy). A 30 min period
of EcoG recording under basal conditions, as well as
before induction of brain ischemia, was taken as basal
value. Brain ischemia was induced by temporary bilateral
occlusion of the common carotid artery (BCCO). Under
anesthesia with ether, the common carotid arteries were
dissected via a ventral neck incision and occluded with lig-
atures for 5 min (day 0). Then, the ligatures were
removed, the skin incision sutured and animals were
allowed to recover. A complete flattening of ECoG activ-
ity, was found for about 10 minutes after BCCO indicat-
ing the occurrence of brain ischemia. Animals that
displayed no post-ischemic ECoG flattening were dis-
carded from the study. Rectal temperature was monitored
and kept between 36°C and 37°C during surgery by
means of a heating pad. In addition, mean arterial blood
pressure (MABP) and blood gases were evaluated immedi-
ately before, during, 5 minutes and 1, 2, 4 and 6 hours
after BCCO either in untreated or M40401-treated gerbils.
Neuropathological studies
1, 3 or 7 days after BCCO, the gerbils were re-anesthetized
with pentobarbital and transcardially perfusion-fixed
with 4% buffered formaldehyde (pH 7.4) after a brief
rinse with saline and heparin (0.1%) at room tempera-
ture. The brains were removed, kept in cold fixative for 2
hours, and stored in phosphate-buffered saline (PBS)
overnight.
Histological stainings for nerve cells were performed to
evaluate general brain morphology and tissue damage.
Briefly, coronal slices of the dorsal hippocampus 400 µm
thick were cut with a vibratome, dehydrated in graded
alcohols and embedded in paraffin. Coronal sections 6 to
7 µm were stained with cresyl violet. The sections were
coverslipped with permount and examined using a light
microscope (Leica). Sham operated animals were used as
a control group: these underwent similar handling but no
BCCO was induced.
For Electron Microscopy studies, coronal sections (10 µm
thick) collected every 50 microns were stained using Nissl
method (cresol fast violet) and examined in a Leitz-ortho-
plan photomicroscope. In particular, animals were per-
fusion-fixed with 0.01 M PBS (pH 7.4) followed by 3%
paraformaldehyde and 0.1% glutaraldehyde in 0.15 M PB
(pH 7.4) at room temperature. The brain was removed,
blocks of the areas of interest were made and these were
postfixed in osmium tetroxide 1.33% for 2 h at 4°C. After
several washes in PBS, the tissue fragments were dehy-
drated in graded alcohol, transferred into toluene, and
embedded in Epon 812 resin. The resin was allowed to
polymerize in a dry oven at 60°C for 24 h. Thin sections
were cut with a glass knife Reichert microtome, stained
with toluidine blue and examined on Axioscope micro-
scope (Zeiss). Ultra-thin sections were cut on a Reichert
microtome using a diamond knife, stained with uranyl-
acetate-lead-hydroxide and evaluated and photographed
on a Philips electron microscope CM10 (Philips, End-
hoven, The Netherlands).
Malondialdehyde Determinations
Malondialdehyde (MDA; used as a biochemical marker
for lipid peroxidation) was measured by a method previ-
ously described [46]. Levels of MDA were measured 1, 3
and 7 days after induction of brain ischemia in untreated
or M40401-treated Mongolian gerbils. Briefly, hippocam-
pal regions of perfused Mongolian gerbils were surgically
identified, removed and then frozen in liquid nitrogen,
and homogenized in potassium chloride (1.15%). Chlo-
roform (2 ml) was then added to each homogenate and
then spun for 30 min.
The organic layer of the sample was removed and dried
under nitrogen gas and re-constituted with 100 µl of
saline. MDA generation was evaluated by the assay of
thiobarbituric acid (TBA)-reacting compounds. The addi-
tion of a solution of 20 µl of sodium dodecyl sulphate
(SDS; 8.1%), 150 µl of 20% acetic acid solution (pH3.5),
150 µl of 0.8% TBA and 400 µl of distilled water, pro-
duced a chromogenic product which was extracted in n-
butanol and pyridine. Then, the organic layer was
removed and MDA levels read at 532 nm and expressed as
nmol MDA/g wet tissue.
Drug administration and experimental groups
M40401 (Metaphore Pharm. Inc., St. Louis) was dissolved
in 26 mM sodium bicarbonate buffer (pH = 8.1–8.3).
M40401 (1–40 mg/kg) was given intraperitoneally (i.p.;
0.3 ml) 1 h after BCCO (day 0). ECoG changes and his-
topathological studies were carried out 1, 3 and 7 days
after M40401 administration. The same drug administra-
tion protocol was performed in sham animals.
Selectivity of M40401
It has been shown that the pentaaza macrocyclic ligand
complexes of Mn(II) can not only be highly active cata-
lysts for the dismutation of O2 
-, but that they are also
highly selective (25). In particular, evidence exists that
this complex and others of this pentaaza macrocyclic lig-
and class, such as M40403 or M40401 do not react with
hydrogen peroxide under the same conditions [25], nor
do they react with other biologically relevant oxidants
such as ONOO- or nitric oxide [25].BMC Pharmacology 2003, 3 http://www.biomedcentral.com/1471-2210/3/8
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Materials
All the reagents used for this study were purchased from
Sigma (Milan). M40401 was kindly provided by Dr. D.P.
Riley (Metaphore Pharm. Inc, St. Louis, Mo, USA).
Statistics
Results are expressed as means ± s.e.m. for n experiments.
The results were analysed independently by at least three
observers and Student's unpaired t test was used to deter-
mine the significance between means. A P value of < 0.05
was taken as significant.
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